The DLEU2, DLEU1, MIRN15A, and MIRN16-1 genes within this cluster, either independently or jointly, play important roles in the pathogenesis, disease progression, and response to treatment regimens in CLL. The gene discussed is DLEU1; the disease is B-cell chronic lymphocytic leukemia.